Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China...
Strategic Spinoffs and Bold Overhauls Across 10 Under-the-Radar Stocks
12 Health Care Stocks Moving In Friday's After-Market Session
Gelteq Limited Advances Clinical Programs and Asia Expansion in First Half of 2026
Gelteq publishes MD&A for six months ended Dec. 31, 2025
Gelteq signs debt financing deal of up to US$3.5 million with institutional investor
U.S. stock intraday update: Gelteq rises 11.64% with increased trading volume, no positive news driving intensified capital speculation